In the past decade, France has established a vibrant biotech sector with a decided focus on clinical drug development. Today, the French healthcare sector is comprised of over 1,800 companies, according to a survey conducted by France Biotech. This includes 720 biotech companies, 73 bio-cleantech companies, 886 companies specialized in medical devices and diagnostics and 200 companies focusing on eHealth. Drawing the investors from around the world to Paris is the opportunity to meet the more than 70 participating companies across biotech, medtech and digital health. One example is Nanobiotix, a Paris-based nanomedicine company developing therapies to enhance the effect that radiation therapy has on various cancers.

Source: Forbes June 20, 2019 20:01 UTC